论文部分内容阅读
对186例中晚期各型肺癌病例,采用选择性支气管动脉及病灶供血动脉插管行DSA,并灌注抗癌药物,近期有效率达96.7％。其中CR9例(4.8％),PR98例(52.7％),S73例(39.2％)P6例(3％)。大部分患者经1个疗程治疗,血痰消失,咳嗽憋气减轻或缓解,食欲体重增加。CT及DSA复查表明,胸部肿块缩小1/3以上,且密度变低交淡,肺不张改善或恢复。并就肺癌动脉灌注化疗中药物选择与剂量,多血管灌注,寻找靶血管成功率及以灌注化疗为主的综合治疗设想等方面进行了探讨。
For 186 cases of lung cancer in late-stage patients, selective bronchial arteries and lesion feeding arteries were used to perform DSA infusion and anticancer drugs were infused. The recent effective rate was 96.7%. Among them, CR9 cases (4.8%), PR98 cases (52.7%), S73 cases (39.2%) P6 cases (3%). Most patients were treated with a course of treatment, blood stasis disappeared, cough phlegm reduced or relieved, and appetite weight increased. CT and DSA reexamination showed that the thoracic mass was reduced by more than 1/3, and the density became dull, and the pulmonary atelectasis improved or recovered. The aspects of drug selection and dose, multi-vessel perfusion, the success rate of finding target vessels and the idea of comprehensive treatment based on infusion chemotherapy in lung cancer arterial infusion chemotherapy were discussed.